Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714451 · ClinicalTrials.gov registry record · NA
Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03714451: Completed NA study, sponsored by Yale University.
NCT03714451 is a NA study that has completed, run by Yale University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03714451, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).
Primary Outcome
The continuous glucose monitoring (CGM) consists of a sensor that measures glucose levels from the interstitial tissue. Changes in glucose levels from baseline.
Interventions
- DIETARY_SUPPLEMENT onyx sorghum
- DIETARY_SUPPLEMENT whole wheat flour
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2022-12-30 |
| Phase | NA |
What the finished NCT03714451 record still lists
NCT03714451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which onyx sorghum is the first listed.
NCT03714451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03714451 about?
NCT03714451 is a clinical study titled "Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes". To evaluate the effect of onyx sorghum on blood glucose levels in patients with type 2 diabetes (T2DM).
What is the current status of trial NCT03714451?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-11-01. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT03714451?
The interventions under investigation include: onyx sorghum (DIETARY_SUPPLEMENT), whole wheat flour (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03714451?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03714451's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI